Infiltrative cardiovascular diseases: cardiomyopathies that look alike

James B Seward1, Grace Casaclang-Verzosa

  • 1Divisions of Cardiovascular Diseases, General Internal Medicine, and Pediatric Cardiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. seward@mayo.edu

Insights

Infiltrative cardiomyopathies stiffen heart walls, mimicking other heart conditions. Diagnosis often requires tissue or blood tests to confirm the specific infiltrative cardiomyopathy and guide treatment.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Infiltrative cardiomyopathies involve abnormal substance deposition, leading to ventricular rigidity and impaired filling.
  • These conditions can present with increased wall thickness or chamber enlargement, mimicking other cardiac diseases like hypertrophic or ischemic cardiomyopathy.
  • While low-voltage QRS complexes suggest infiltrative cardiomyopathy (e.g., cardiac amyloidosis), this finding is not universal.

Purpose of the Study:

  • To differentiate infiltrative cardiomyopathies from other cardiac conditions based on clinical presentation and imaging features.
  • To highlight the diagnostic challenges posed by the varied presentations of infiltrative cardiomyopathies.
  • To emphasize the necessity of definitive diagnostic methods for appropriate patient management.

Main Methods:

  • Review of clinical presentations of infiltrative cardiomyopathies.
  • Analysis of functional and morphologic cardiac features.
  • Discussion of diagnostic criteria and confirmatory tests.

Main Results:

  • Infiltrative cardiomyopathies can mimic hypertrophic cardiomyopathy (thickening) or ischemic cardiomyopathy (dilated chambers, wall motion abnormalities).
  • Low-voltage QRS on electrocardiogram is suggestive but not consistently present in all infiltrative cardiomyopathies.
  • Clinical and imaging findings provide initial diagnostic clues, but definitive diagnosis often relies on tissue or serologic evaluation.

Conclusions:

  • Accurate diagnosis of infiltrative cardiomyopathies relies on integrating clinical, imaging, and electrocardiographic data.
  • Distinguishing infiltrative cardiomyopathies from other heart diseases is crucial for effective therapeutic strategies.
  • Tissue or serologic confirmation is frequently required to establish a definitive diagnosis and initiate appropriate treatment for infiltrative cardiomyopathies.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...